https://www.marketscreener.com/quote/stock/AIM-IMMUNOTECH-INC-65218228/news/AIM-ImmunoTech-Announces-Phase-2a-Human-Challenge-Trial-to-Test-its-Drug-Ampligen-as-an-Intranasal-35825934/?utm_source=telegram&utm_medium=social&utm_campaign=share